Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6267 posts found.

CytoSorbents announces EU launch and availability of PuriFi blood pump

June 14, 2024 Medical Communications CytoSorbents, EU, Haematology, PuriFi, blood pump

CytoSorbents Corporation has announced the launch and immediate availability of its PuriFi haemoperfusion machine in the EU following its approval …
News

Tracon shares data from phase 2 trial for glioblastoma treatment

June 12, 2024 Medical Communications Oncology, Tracon Pharmaceuticals, clinical tria, clinical trial, glioblastoma

Tracon Pharmaceuticals has announced the publication of its phase 2 clinical data for its DNA damage repair inhibitor drug candidate, …
News
robina-weermeijer-ihfopazzjhm-unsplash_5

FDA accepts Eisai’s Leqembi sBLA for early AD treatment

June 11, 2024 Medical Communications Alzheimer's, Biogen, FDA, Neurology, sBLA

Eisai and Biogen have announced that the US Food and Drug Administration (FDA) has accepted Eisai’s supplemental biologics license application …
News

Santhera announces Early Access Program by partner Sperogenix for DMD treatment

June 11, 2024 Medical Communications DMD, Musculo-skeletal disorder, early access, muscular dystrophy, santhera

Santhera Pharmaceuticals has announced that its partner Sperogenix Therapeutics has launched a paid-for Early Access Program (EAP) for Agamree (vamorolone) …
News

GSK’s Arexvy vaccine approved by FDA for RSV prevention in adult patients

June 10, 2024 Medical Communications FDA, GSK, Immunology, Vaccine

GSK has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine, Adjuvanted) …
News
yunus-tug-lnfgdbcajxu-unsplash

FDA approves Geron’s Rytelo for treatment of MDS with transfusion-dependent anaemia

June 7, 2024 Medical Communications FDA, Geron, Haematology, anaemia, mds

Geron Corporation has announced that the US Food and Drug Administration (FDA) has approved Rytelo (imetelstat) for the treatment of …
News

AbbVie initiates phase 3 multiple myeloma trial

June 6, 2024 Medical Communications ABBV-383, AbbVie, Oncology, clinical trial, multiple myeloma

AbbVie has announced that it has dosed the first patient in its phase 3 CERVINO trial, which aims to assess …
News

Quince Therapeutics gains FDA Fast Track Designation for EryDex System

June 4, 2024 Medical Communications EryDex, FDA, Quince Therapeutics, Rare Diseases, fast track designation

Quince Therapeutics has announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation for its EryDex …
News

Oryzon Genomics announces publication of phase 2a ALICE trial results

June 4, 2024 Medical Communications AML, Oncology, Oryzon genomics, acute myeloid leukaemia, clinical trial

Oryzon Genomics has announced that the final results from its phase 2a ALICE study have been published online in The …
News

CHMP recommends AstraZeneca’s Tagrisso for approval for lung cancer treatment

June 3, 2024 Medical Communications CHMP, EMA, Oncology, Tagrisso, lung cancer

AstraZeneca has announced that Tagrisso (osimertinib) alongside pemetrexed and platinum-based chemotherapy, has been recommended for approval in the EU for …
News

AbbVie gains positive CHMP opinion for Skyrizi for treatment of UC

May 31, 2024 Medical Communications AbbVie, EMA, Gastrointestinal tract, Skyrizi, ulcerative colitis

AbbVie has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has granted a …
News

Eli Lilly and UNICEF expand support for young people at risk of noncommunicable diseases

May 30, 2024 Medical Communications Eli Lilly, Pharmacy, Unicef, investment, noncommunicable diseases

Eli Lilly has announced that it will donate $6.5m to the United States Fund for UNICEF in order to expand …
News

Full-Life Technologies’ IND application for prostate cancer cleared by FDA

May 30, 2024 Medical Communications Full-Life Technologies, IND, Oncology, prostate cancer

Full-Life Technologies has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) Application …
News

Sanofi’s Sarclisa accepted for FDA priority review

May 29, 2024 Medical Communications FDA, Oncology, Sanofim, Sarclisa, multiple myeloma, priority review

Sanofi has announced that the US Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for …
News

Merck shares data from phase 3 trial of Keytruda for TNBC treatment

May 29, 2024 Medical Communications Merck, Oncology, breast cancer, clinical trial, keytruda

Merck, known as MSD outside of the US and Canada, has announced results from the phase 3 KEYNOTE-522 trial, which …
News

Latest content

AstraZeneca’s Imfinzi approved in US for endometrial cancer treatment

June 17, 2024

Innate Pharma shares results from phase 1/2 trial for blood cancer treatment

June 17, 2024

CytoSorbents announces EU launch and availability of PuriFi blood pump

June 14, 2024

AbbVie and FutureGen announce license agreement for IBD therapy

June 14, 2024

Pfizer shares update on DMD gene therapy clinical trial

June 13, 2024